Thrombosis News and Research

Latest Thrombosis News and Research

Anticoagulation after primary PCI does not prevent adverse outcomes in STEMI patients

Anticoagulation after primary percutaneous coronary intervention (PCI) does not prevent adverse outcomes in patients with ST-segment elevation myocardial infarction (STEMI), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

SGLT2 inhibitors do not reduce 28-day mortality in hospitalized COVID-19 patients

Sodium glucose co-transporter-2 (SGLT2) inhibitors do not lead to lower 28-day all-cause mortality compared with usual care or placebo in patients hospitalized with COVID-19, according to late-breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

Longer duration of anticoagulation therapy benefits cancer patients with isolated distal DVT

Twelve months of edoxaban is superior to three months for the reduction of thrombotic events in patients with cancer and distal deep vein thrombosis (DVT), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

29 Aug 2023

OCT-guided PCI does not reduce target vessel failure in complex patients, but improves safety

Optical coherence tomography (OCT)-guided percutaneous coronary intervention (PCI) leads to a larger minimum stent area but does not reduce the two-year rate of target vessel failure compared with angiography-guided PCI, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

Switching to NOACs in frail elderly patients with atrial fibrillation increases bleeding risk

Switching vitamin K antagonist (VKA) treatment to a non-vitamin K antagonist oral anticoagulant (NOAC) in frail elderly patients with atrial fibrillation is associated with more bleeding complications compared to continuing VKA treatment.

28 Aug 2023

Intravascular imaging-guided PCI associated with lower rate of target lesion failure

Intravascular imaging-guided percutaneous coronary intervention (PCI) is associated with a lower rate of target lesion failure compared with angiography-guided PCI, according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

Dual-antiplatelet therapy should remain the standard strategy for PCI even in the drug-eluting stent era

Prasugrel monotherapy after percutaneous coronary intervention (PCI) with drug-eluting stents is not superior to dual-antiplatelet therapy (DAPT) for major bleeding but is non-inferior for cardiovascular events in patients with acute coronary syndrome (ACS) or high bleeding risk (HBR), according to late breaking research presented in a Hot Line session today at ESC Congress 2023.

28 Aug 2023

New DNA-based anticoagulant could treat heparin-induced thrombocytopenia

Various medical circumstances, including heart attacks and extreme cases of COVID-19, necessitate the use of anticoagulants, medicines that prevent blood clots

21 Aug 2023

Adenovirus infection linked to rare blood clotting disorder

Platelets, or thrombocytes, are specialized cellular fragments that form blood clots when we get scrapes and traumatic injuries. Viral infections, autoimmune disease, and other conditions can cause platelet levels to drop throughout the body, termed thrombocytopenia.

10 Aug 2023

Study explores changes in cardiovascular disease hospitalization trends during the COVID-19 pandemic

A group of researchers examined the variations in cardiovascular disease hospitalizations pre- and post-COVID-19 pandemic.

10 Aug 2023

Exploring the safety of COVID-19 mRNA vaccines in the elderly

Researchers evaluate the risks of possible adverse events following COVID-19 mRNA vaccination in the elderly.

7 Aug 2023

Is COVID-19 vaccination protective against thrombotic complications?

Researchers explore the potential association of both arterial and venous thrombosis with COVID-19 vaccination.

31 Jul 2023

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes

A group of researchers compared the effects of angiotensin-converting enzyme inhibitors (ACEi) and angiotensin II receptor blockers.

27 Jul 2023

Brazilian researchers identify new way to stop excessive inflammation in COVID-19

Researchers at the University of São Paulo (USP) in Brazil have identified a new class of molecules capable of stopping the excessive inflammation typical of the severe form of COVID-19 without impairing the immune response to SARS-CoV-2, the virus that causes the disease.

25 Jul 2023

American Heart Association calls for more research on e-cigarettes

Research increasingly reveals health risks of e-cigarette use, and more studies are needed about the long-term impact e-cigarettes may have on the heart and lungs, according to a new scientific statement from the American Heart Association published today in the Association's flagship journal Circulation.

17 Jul 2023

Thrombosis News and Research

Latest Thrombosis News and Research

Anticoagulation after primary PCI does not prevent adverse outcomes in STEMI patients

SGLT2 inhibitors do not reduce 28-day mortality in hospitalized COVID-19 patients

Longer duration of anticoagulation therapy benefits cancer patients with isolated distal DVT

OCT-guided PCI does not reduce target vessel failure in complex patients, but improves safety

Switching to NOACs in frail elderly patients with atrial fibrillation increases bleeding risk

Intravascular imaging-guided PCI associated with lower rate of target lesion failure

Dual-antiplatelet therapy should remain the standard strategy for PCI even in the drug-eluting stent era

New DNA-based anticoagulant could treat heparin-induced thrombocytopenia

Adenovirus infection linked to rare blood clotting disorder

Study explores changes in cardiovascular disease hospitalization trends during the COVID-19 pandemic

Exploring the safety of COVID-19 mRNA vaccines in the elderly

Is COVID-19 vaccination protective against thrombotic complications?

COVID-19 treatment: study evaluates ACEi and ARB effects on clinical outcomes

Brazilian researchers identify new way to stop excessive inflammation in COVID-19

American Heart Association calls for more research on e-cigarettes

The causative role of age-associated pre-existing senescent cells on COVID-19 severity

New CHEST guideline offers recommendations to manage arterial thrombosis and thromboembolism in COVID-19

Is consuming ultra-processed foods associated with an increased risk of venous thromboembolisms?

Climate change threatens human health: Urgent action needed to address inequities and reduce carbon footprint

Investigating the relationship between red blood cells and the clinical course of COVID-19 in children

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Thrombosis News and Research

Latest Thrombosis News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in